Moody’s also affirmed the “Aa3” rating on Cedars Sinai’s $960 million of debt.
The rating assignment and affirmation are based on a number of factors, including Cedars-Sinai’s large size, strong reputation and excellent financial performance.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that Cedars-Sinai will continue to grow patient volumes and revenue.
More articles on healthcare finance:
MIPS breakdown: 7 must-know parts of the MACRA final rule
BuildMyBod launches price database for ASCs and other providers
Baltimore EDs see $80M spent on gunshot wounds over last 5 years
